{"title":"Increasing patient awareness of ketoacidosis with gliflozins","authors":"Angus Thompson","doi":"10.1002/psb.2132","DOIUrl":null,"url":null,"abstract":"While SGLT2 inhibitors are generally well tolerated, their use has been associated with cases of ketoacidosis. It is therefore important to make patients aware of what steps they can take to minimise the risk of this potentially serious adverse effect.","PeriodicalId":20432,"journal":{"name":"Prescriber","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
While SGLT2 inhibitors are generally well tolerated, their use has been associated with cases of ketoacidosis. It is therefore important to make patients aware of what steps they can take to minimise the risk of this potentially serious adverse effect.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
